ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Noninvasive Cancer Diagnostics and Technology Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-14E10849
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Noninvasive Cancer Diagnostics Technology Market Research Report 2022
BUY CHAPTERS

Global Noninvasive Cancer Diagnostics and Technology Market Research Report 2025

Code: QYRE-Auto-14E10849
Report
January 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Precision Therapeutics
Affymetrix Inc
Aviva Biosciences Corporation
A&G Pharmaceutical
BioView
Quest Diagnostics Incorporated
Digene Corporation
Laboratory Corporation of America Holdings
Gen-Probe Incorporated
GRAIL
Illumina Inc
Biocept
Guardant Health
Exact Sciences
Konica Minolta

Noninvasive Cancer Diagnostics and Technology Market Size

The global market for Noninvasive Cancer Diagnostics and Technology was valued at US$ 1530 million in the year 2024 and is projected to reach a revised size of US$ 2480 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Noninvasive Cancer Diagnostics and Technology Market

Noninvasive Cancer Diagnostics and Technology Market

Noninvasive cancer diagnostics and technology refer to methods and devices used to detect and diagnose cancer without the need for invasive procedures such as surgery or biopsies. These approaches aim to minimize patient discomfort, risk, and recovery time, while providing accurate and timely cancer detection.
The global noninvasive cancer diagnostics and technology market refers to the market for diagnostic tools and technologies that are used to detect and diagnose cancer without the need for invasive procedures such as biopsies or surgeries. These noninvasive methods are typically less painful, less risky, and offer quicker results compared to traditional diagnostic techniques.
The demand for noninvasive cancer diagnostics and technology has been increasing worldwide due to the rising prevalence of cancer and the need for early detection and accurate diagnosis. Noninvasive methods can include imaging techniques, liquid biopsies, molecular testing, genetic testing, and other innovative technologies.
Imaging techniques such as MRI, CT scans, ultrasound, and PET scans play a significant role in noninvasive cancer diagnosis by providing detailed images of the affected area. These imaging technologies help identify the location, size, and extent of tumors, enabling oncologists to make informed decisions regarding treatment plans.
Liquid biopsies have gained considerable attention in recent years for their ability to detect cancer-related biomarkers in blood samples. These tests analyze circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other components present in the bloodstream, providing valuable information about the presence of cancer, its stage, and potential treatment options.
Molecular testing and genetic testing also contribute to noninvasive cancer diagnostics by analyzing genetic mutations and alterations in tumors. These tests help identify specific genetic markers associated with different types of cancer, allowing for personalized treatment approaches and monitoring of therapy effectiveness.
The global noninvasive cancer diagnostics and technology market is highly competitive and fragmented, with numerous companies specializing in different diagnostic modalities. Key players in the market include manufacturers of imaging equipment, diagnostic laboratories, biotechnology companies, and pharmaceutical companies.
North America currently dominates the market, driven by advanced healthcare infrastructure, increasing cancer prevalence, and high adoption of novel diagnostic technologies. Europe is also a significant market, with a focus on early cancer detection and personalized medicine. Furthermore, emerging markets in Asia Pacific and Latin America are witnessing rapid growth due to improving healthcare infrastructure, rising awareness, and government initiatives to combat cancer.
Factors driving market growth include technological advancements, increasing research and development activities, a growing emphasis on personalized medicine, and the rising demand for noninvasive diagnostic techniques. However, high costs associated with advanced diagnostic tools and limited reimbursement coverage in some regions could hinder market growth.
In conclusion, the global noninvasive cancer diagnostics and technology market is expanding due to the demand for early detection, accurate diagnosis, and personalized treatment options. Noninvasive diagnostic techniques, such as imaging, liquid biopsies, and genetic testing, offer significant advantages over invasive procedures and are expected to play a crucial role in the future of cancer diagnosis and treatment.The global noninvasive cancer diagnostics and technology market refers to the market for diagnostic tools and technologies that are used to detect and diagnose cancer without the need for invasive procedures such as biopsies or surgeries. These noninvasive methods are typically less painful, less risky, and offer quicker results compared to traditional diagnostic techniques.
The demand for noninvasive cancer diagnostics and technology has been increasing worldwide due to the rising prevalence of cancer and the need for early detection and accurate diagnosis. Noninvasive methods can include imaging techniques, liquid biopsies, molecular testing, genetic testing, and other innovative technologies.
Imaging techniques such as MRI, CT scans, ultrasound, and PET scans play a significant role in noninvasive cancer diagnosis by providing detailed images of the affected area. These imaging technologies help identify the location, size, and extent of tumors, enabling oncologists to make informed decisions regarding treatment plans.
Liquid biopsies have gained considerable attention in recent years for their ability to detect cancer-related biomarkers in blood samples. These tests analyze circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other components present in the bloodstream, providing valuable information about the presence of cancer, its stage, and potential treatment options.
Molecular testing and genetic testing also contribute to noninvasive cancer diagnostics by analyzing genetic mutations and alterations in tumors. These tests help identify specific genetic markers associated with different types of cancer, allowing for personalized treatment approaches and monitoring of therapy effectiveness.
The global noninvasive cancer diagnostics and technology market is highly competitive and fragmented, with numerous companies specializing in different diagnostic modalities. Key players in the market include manufacturers of imaging equipment, diagnostic laboratories, biotechnology companies, and pharmaceutical companies.
North America currently dominates the market, driven by advanced healthcare infrastructure, increasing cancer prevalence, and high adoption of novel diagnostic technologies. Europe is also a significant market, with a focus on early cancer detection and personalized medicine. Furthermore, emerging markets in Asia Pacific and Latin America are witnessing rapid growth due to improving healthcare infrastructure, rising awareness, and government initiatives to combat cancer.
Factors driving market growth include technological advancements, increasing research and development activities, a growing emphasis on personalized medicine, and the rising demand for noninvasive diagnostic techniques. However, high costs associated with advanced diagnostic tools and limited reimbursement coverage in some regions could hinder market growth.
In conclusion, the global noninvasive cancer diagnostics and technology market is expanding due to the demand for early detection, accurate diagnosis, and personalized treatment options. Noninvasive diagnostic techniques, such as imaging, liquid biopsies, and genetic testing, offer significant advantages over invasive procedures and are expected to play a crucial role in the future of cancer diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Noninvasive Cancer Diagnostics and Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Noninvasive Cancer Diagnostics and Technology.
The Noninvasive Cancer Diagnostics and Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Noninvasive Cancer Diagnostics and Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Noninvasive Cancer Diagnostics and Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Noninvasive Cancer Diagnostics and Technology Market Report

Report Metric Details
Report Name Noninvasive Cancer Diagnostics and Technology Market
Accounted market size in year US$ 1530 million
Forecasted market size in 2031 US$ 2480 million
CAGR 7.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Medical Device Manufacturing Companies
  • Hospitals and Clinics
  • Oncology Laboratories
  • Private Research Institutions
  • Academic Institutions
  • Pharmaceutical Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BIOVIEW Inc., Affymetrix Inc., Precision Therapeutics, Digene Corporation, A&G Pharmaceutical, Gen-Probe Incorporated, AVIVA Biosciences Corporation, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Guardant Health, Exact Sciences, GRAIL, Konica Minolta, Illumina, Biocept
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Noninvasive Cancer Diagnostics and Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Noninvasive Cancer Diagnostics and Technology Market growing?

Ans: The Noninvasive Cancer Diagnostics and Technology Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Noninvasive Cancer Diagnostics and Technology Market size in 2031?

Ans: The Noninvasive Cancer Diagnostics and Technology Market size in 2031 will be US$ 2480 million.

Who are the main players in the Noninvasive Cancer Diagnostics and Technology Market report?

Ans: The main players in the Noninvasive Cancer Diagnostics and Technology Market are BIOVIEW Inc., Affymetrix Inc., Precision Therapeutics, Digene Corporation, A&G Pharmaceutical, Gen-Probe Incorporated, AVIVA Biosciences Corporation, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Guardant Health, Exact Sciences, GRAIL, Konica Minolta, Illumina, Biocept

What are the Application segmentation covered in the Noninvasive Cancer Diagnostics and Technology Market report?

Ans: The Applications covered in the Noninvasive Cancer Diagnostics and Technology Market report are Medical Device Manufacturing Companies, Hospitals and Clinics, Oncology Laboratories, Private Research Institutions, Academic Institutions, Pharmaceutical Companies, Others

What are the Type segmentation covered in the Noninvasive Cancer Diagnostics and Technology Market report?

Ans: The Types covered in the Noninvasive Cancer Diagnostics and Technology Market report are Immunoassays, Molecular Diagnostics, Clinical Chemistry, Other

Recommended Reports

Cancer Diagnostics Solutions

Liquid Biopsy Markets

Molecular Testing Advances

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassays
1.2.3 Molecular Diagnostics
1.2.4 Clinical Chemistry
1.2.5 Other
1.3 Market by Application
1.3.1 Global Noninvasive Cancer Diagnostics and Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Device Manufacturing Companies
1.3.3 Hospitals and Clinics
1.3.4 Oncology Laboratories
1.3.5 Private Research Institutions
1.3.6 Academic Institutions
1.3.7 Pharmaceutical Companies
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Cancer Diagnostics and Technology Market Perspective (2020-2031)
2.2 Global Noninvasive Cancer Diagnostics and Technology Growth Trends by Region
2.2.1 Global Noninvasive Cancer Diagnostics and Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Noninvasive Cancer Diagnostics and Technology Historic Market Size by Region (2020-2025)
2.2.3 Noninvasive Cancer Diagnostics and Technology Forecasted Market Size by Region (2026-2031)
2.3 Noninvasive Cancer Diagnostics and Technology Market Dynamics
2.3.1 Noninvasive Cancer Diagnostics and Technology Industry Trends
2.3.2 Noninvasive Cancer Diagnostics and Technology Market Drivers
2.3.3 Noninvasive Cancer Diagnostics and Technology Market Challenges
2.3.4 Noninvasive Cancer Diagnostics and Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Cancer Diagnostics and Technology Players by Revenue
3.1.1 Global Top Noninvasive Cancer Diagnostics and Technology Players by Revenue (2020-2025)
3.1.2 Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Players (2020-2025)
3.2 Global Noninvasive Cancer Diagnostics and Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Noninvasive Cancer Diagnostics and Technology Revenue
3.4 Global Noninvasive Cancer Diagnostics and Technology Market Concentration Ratio
3.4.1 Global Noninvasive Cancer Diagnostics and Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Cancer Diagnostics and Technology Revenue in 2024
3.5 Global Key Players of Noninvasive Cancer Diagnostics and Technology Head office and Area Served
3.6 Global Key Players of Noninvasive Cancer Diagnostics and Technology, Product and Application
3.7 Global Key Players of Noninvasive Cancer Diagnostics and Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Cancer Diagnostics and Technology Breakdown Data by Type
4.1 Global Noninvasive Cancer Diagnostics and Technology Historic Market Size by Type (2020-2025)
4.2 Global Noninvasive Cancer Diagnostics and Technology Forecasted Market Size by Type (2026-2031)
5 Noninvasive Cancer Diagnostics and Technology Breakdown Data by Application
5.1 Global Noninvasive Cancer Diagnostics and Technology Historic Market Size by Application (2020-2025)
5.2 Global Noninvasive Cancer Diagnostics and Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Noninvasive Cancer Diagnostics and Technology Market Size (2020-2031)
6.2 North America Noninvasive Cancer Diagnostics and Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025)
6.4 North America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Noninvasive Cancer Diagnostics and Technology Market Size (2020-2031)
7.2 Europe Noninvasive Cancer Diagnostics and Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025)
7.4 Europe Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size (2020-2031)
8.2 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Noninvasive Cancer Diagnostics and Technology Market Size (2020-2031)
9.2 Latin America Noninvasive Cancer Diagnostics and Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025)
9.4 Latin America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size (2020-2031)
10.2 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BIOVIEW Inc.
11.1.1 BIOVIEW Inc. Company Details
11.1.2 BIOVIEW Inc. Business Overview
11.1.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Introduction
11.1.4 BIOVIEW Inc. Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.1.5 BIOVIEW Inc. Recent Development
11.2 Affymetrix Inc.
11.2.1 Affymetrix Inc. Company Details
11.2.2 Affymetrix Inc. Business Overview
11.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Introduction
11.2.4 Affymetrix Inc. Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.2.5 Affymetrix Inc. Recent Development
11.3 Precision Therapeutics
11.3.1 Precision Therapeutics Company Details
11.3.2 Precision Therapeutics Business Overview
11.3.3 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Introduction
11.3.4 Precision Therapeutics Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.3.5 Precision Therapeutics Recent Development
11.4 Digene Corporation
11.4.1 Digene Corporation Company Details
11.4.2 Digene Corporation Business Overview
11.4.3 Digene Corporation Noninvasive Cancer Diagnostics and Technology Introduction
11.4.4 Digene Corporation Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.4.5 Digene Corporation Recent Development
11.5 A&G Pharmaceutical
11.5.1 A&G Pharmaceutical Company Details
11.5.2 A&G Pharmaceutical Business Overview
11.5.3 A&G Pharmaceutical Noninvasive Cancer Diagnostics and Technology Introduction
11.5.4 A&G Pharmaceutical Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.5.5 A&G Pharmaceutical Recent Development
11.6 Gen-Probe Incorporated
11.6.1 Gen-Probe Incorporated Company Details
11.6.2 Gen-Probe Incorporated Business Overview
11.6.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Introduction
11.6.4 Gen-Probe Incorporated Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.6.5 Gen-Probe Incorporated Recent Development
11.7 AVIVA Biosciences Corporation
11.7.1 AVIVA Biosciences Corporation Company Details
11.7.2 AVIVA Biosciences Corporation Business Overview
11.7.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Introduction
11.7.4 AVIVA Biosciences Corporation Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.7.5 AVIVA Biosciences Corporation Recent Development
11.8 Quest Diagnostics Incorporated
11.8.1 Quest Diagnostics Incorporated Company Details
11.8.2 Quest Diagnostics Incorporated Business Overview
11.8.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Introduction
11.8.4 Quest Diagnostics Incorporated Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.8.5 Quest Diagnostics Incorporated Recent Development
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Details
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.9.5 Laboratory Corporation of America Holdings Recent Development
11.10 Guardant Health
11.10.1 Guardant Health Company Details
11.10.2 Guardant Health Business Overview
11.10.3 Guardant Health Noninvasive Cancer Diagnostics and Technology Introduction
11.10.4 Guardant Health Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.10.5 Guardant Health Recent Development
11.11 Exact Sciences
11.11.1 Exact Sciences Company Details
11.11.2 Exact Sciences Business Overview
11.11.3 Exact Sciences Noninvasive Cancer Diagnostics and Technology Introduction
11.11.4 Exact Sciences Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.11.5 Exact Sciences Recent Development
11.12 GRAIL
11.12.1 GRAIL Company Details
11.12.2 GRAIL Business Overview
11.12.3 GRAIL Noninvasive Cancer Diagnostics and Technology Introduction
11.12.4 GRAIL Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.12.5 GRAIL Recent Development
11.13 Konica Minolta
11.13.1 Konica Minolta Company Details
11.13.2 Konica Minolta Business Overview
11.13.3 Konica Minolta Noninvasive Cancer Diagnostics and Technology Introduction
11.13.4 Konica Minolta Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.13.5 Konica Minolta Recent Development
11.14 Illumina
11.14.1 Illumina Company Details
11.14.2 Illumina Business Overview
11.14.3 Illumina Noninvasive Cancer Diagnostics and Technology Introduction
11.14.4 Illumina Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.14.5 Illumina Recent Development
11.15 Biocept
11.15.1 Biocept Company Details
11.15.2 Biocept Business Overview
11.15.3 Biocept Noninvasive Cancer Diagnostics and Technology Introduction
11.15.4 Biocept Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
11.15.5 Biocept Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Precision Therapeutics
Affymetrix Inc
Aviva Biosciences Corporation
A&G Pharmaceutical
BioView
Quest Diagnostics Incorporated
Digene Corporation
Laboratory Corporation of America Holdings
Gen-Probe Incorporated
GRAIL
Illumina Inc
Biocept
Guardant Health
Exact Sciences
Konica Minolta
List of Tables
 Table 1. Global Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunoassays
 Table 3. Key Players of Molecular Diagnostics
 Table 4. Key Players of Clinical Chemistry
 Table 5. Key Players of Other
 Table 6. Global Noninvasive Cancer Diagnostics and Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Noninvasive Cancer Diagnostics and Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Noninvasive Cancer Diagnostics and Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Noninvasive Cancer Diagnostics and Technology Market Share by Region (2020-2025)
 Table 10. Global Noninvasive Cancer Diagnostics and Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Noninvasive Cancer Diagnostics and Technology Market Share by Region (2026-2031)
 Table 12. Noninvasive Cancer Diagnostics and Technology Market Trends
 Table 13. Noninvasive Cancer Diagnostics and Technology Market Drivers
 Table 14. Noninvasive Cancer Diagnostics and Technology Market Challenges
 Table 15. Noninvasive Cancer Diagnostics and Technology Market Restraints
 Table 16. Global Noninvasive Cancer Diagnostics and Technology Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Noninvasive Cancer Diagnostics and Technology Market Share by Players (2020-2025)
 Table 18. Global Top Noninvasive Cancer Diagnostics and Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics and Technology as of 2024)
 Table 19. Ranking of Global Top Noninvasive Cancer Diagnostics and Technology Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Noninvasive Cancer Diagnostics and Technology Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Noninvasive Cancer Diagnostics and Technology, Headquarters and Area Served
 Table 22. Global Key Players of Noninvasive Cancer Diagnostics and Technology, Product and Application
 Table 23. Global Key Players of Noninvasive Cancer Diagnostics and Technology, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Noninvasive Cancer Diagnostics and Technology Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Type (2020-2025)
 Table 27. Global Noninvasive Cancer Diagnostics and Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Type (2026-2031)
 Table 29. Global Noninvasive Cancer Diagnostics and Technology Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Application (2020-2025)
 Table 31. Global Noninvasive Cancer Diagnostics and Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Application (2026-2031)
 Table 33. North America Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 48. BIOVIEW Inc. Company Details
 Table 49. BIOVIEW Inc. Business Overview
 Table 50. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Product
 Table 51. BIOVIEW Inc. Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 52. BIOVIEW Inc. Recent Development
 Table 53. Affymetrix Inc. Company Details
 Table 54. Affymetrix Inc. Business Overview
 Table 55. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Product
 Table 56. Affymetrix Inc. Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 57. Affymetrix Inc. Recent Development
 Table 58. Precision Therapeutics Company Details
 Table 59. Precision Therapeutics Business Overview
 Table 60. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Product
 Table 61. Precision Therapeutics Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 62. Precision Therapeutics Recent Development
 Table 63. Digene Corporation Company Details
 Table 64. Digene Corporation Business Overview
 Table 65. Digene Corporation Noninvasive Cancer Diagnostics and Technology Product
 Table 66. Digene Corporation Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 67. Digene Corporation Recent Development
 Table 68. A&G Pharmaceutical Company Details
 Table 69. A&G Pharmaceutical Business Overview
 Table 70. A&G Pharmaceutical Noninvasive Cancer Diagnostics and Technology Product
 Table 71. A&G Pharmaceutical Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 72. A&G Pharmaceutical Recent Development
 Table 73. Gen-Probe Incorporated Company Details
 Table 74. Gen-Probe Incorporated Business Overview
 Table 75. Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Product
 Table 76. Gen-Probe Incorporated Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 77. Gen-Probe Incorporated Recent Development
 Table 78. AVIVA Biosciences Corporation Company Details
 Table 79. AVIVA Biosciences Corporation Business Overview
 Table 80. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Product
 Table 81. AVIVA Biosciences Corporation Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 82. AVIVA Biosciences Corporation Recent Development
 Table 83. Quest Diagnostics Incorporated Company Details
 Table 84. Quest Diagnostics Incorporated Business Overview
 Table 85. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Product
 Table 86. Quest Diagnostics Incorporated Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 87. Quest Diagnostics Incorporated Recent Development
 Table 88. Laboratory Corporation of America Holdings Company Details
 Table 89. Laboratory Corporation of America Holdings Business Overview
 Table 90. Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Product
 Table 91. Laboratory Corporation of America Holdings Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 92. Laboratory Corporation of America Holdings Recent Development
 Table 93. Guardant Health Company Details
 Table 94. Guardant Health Business Overview
 Table 95. Guardant Health Noninvasive Cancer Diagnostics and Technology Product
 Table 96. Guardant Health Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 97. Guardant Health Recent Development
 Table 98. Exact Sciences Company Details
 Table 99. Exact Sciences Business Overview
 Table 100. Exact Sciences Noninvasive Cancer Diagnostics and Technology Product
 Table 101. Exact Sciences Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 102. Exact Sciences Recent Development
 Table 103. GRAIL Company Details
 Table 104. GRAIL Business Overview
 Table 105. GRAIL Noninvasive Cancer Diagnostics and Technology Product
 Table 106. GRAIL Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 107. GRAIL Recent Development
 Table 108. Konica Minolta Company Details
 Table 109. Konica Minolta Business Overview
 Table 110. Konica Minolta Noninvasive Cancer Diagnostics and Technology Product
 Table 111. Konica Minolta Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 112. Konica Minolta Recent Development
 Table 113. Illumina Company Details
 Table 114. Illumina Business Overview
 Table 115. Illumina Noninvasive Cancer Diagnostics and Technology Product
 Table 116. Illumina Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 117. Illumina Recent Development
 Table 118. Biocept Company Details
 Table 119. Biocept Business Overview
 Table 120. Biocept Noninvasive Cancer Diagnostics and Technology Product
 Table 121. Biocept Revenue in Noninvasive Cancer Diagnostics and Technology Business (2020-2025) & (US$ Million)
 Table 122. Biocept Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Noninvasive Cancer Diagnostics and Technology Picture
 Figure 2. Global Noninvasive Cancer Diagnostics and Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Noninvasive Cancer Diagnostics and Technology Market Share by Type: 2024 VS 2031
 Figure 4. Immunoassays Features
 Figure 5. Molecular Diagnostics Features
 Figure 6. Clinical Chemistry Features
 Figure 7. Other Features
 Figure 8. Global Noninvasive Cancer Diagnostics and Technology Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Noninvasive Cancer Diagnostics and Technology Market Share by Application: 2024 VS 2031
 Figure 10. Medical Device Manufacturing Companies Case Studies
 Figure 11. Hospitals and Clinics Case Studies
 Figure 12. Oncology Laboratories Case Studies
 Figure 13. Private Research Institutions Case Studies
 Figure 14. Academic Institutions Case Studies
 Figure 15. Pharmaceutical Companies Case Studies
 Figure 16. Others Case Studies
 Figure 17. Noninvasive Cancer Diagnostics and Technology Report Years Considered
 Figure 18. Global Noninvasive Cancer Diagnostics and Technology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Noninvasive Cancer Diagnostics and Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Noninvasive Cancer Diagnostics and Technology Market Share by Region: 2024 VS 2031
 Figure 21. Global Noninvasive Cancer Diagnostics and Technology Market Share by Players in 2024
 Figure 22. Global Top Noninvasive Cancer Diagnostics and Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics and Technology as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Noninvasive Cancer Diagnostics and Technology Revenue in 2024
 Figure 24. North America Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Noninvasive Cancer Diagnostics and Technology Market Share by Country (2020-2031)
 Figure 26. United States Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Noninvasive Cancer Diagnostics and Technology Market Share by Country (2020-2031)
 Figure 30. Germany Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Share by Region (2020-2031)
 Figure 38. China Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Noninvasive Cancer Diagnostics and Technology Market Share by Country (2020-2031)
 Figure 46. Mexico Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Share by Country (2020-2031)
 Figure 50. Turkey Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Noninvasive Cancer Diagnostics and Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. BIOVIEW Inc. Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 54. Affymetrix Inc. Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 55. Precision Therapeutics Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 56. Digene Corporation Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 57. A&G Pharmaceutical Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 58. Gen-Probe Incorporated Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 59. AVIVA Biosciences Corporation Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 60. Quest Diagnostics Incorporated Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 61. Laboratory Corporation of America Holdings Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 62. Guardant Health Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 63. Exact Sciences Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 64. GRAIL Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 65. Konica Minolta Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 66. Illumina Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 67. Biocept Revenue Growth Rate in Noninvasive Cancer Diagnostics and Technology Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Noninvasive Cancer Biomarkers Market Research Report 2024
Global Non Invasive Cancer Detection Market Research Report 2024
Non Invasive Cancer Diagnostics Market
Precision Cancer Diagnostic Tests Market
Global Noninvasive Diagnostics Market Insights Forecast to 2030
Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030
Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030
Global Precision Cancer Tests Market Research Report 2024
Precision Cancer Imaging Market
Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024
Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030
Global Skin Cancer Diagnostic Equipment Market Research Report 2024
Global Non invasive Diagnosis Market Research Report 2025
Non Ionizing Breast Imaging Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ovarian Cancer Diagnostics Technologies Market Insights Forecast to 2030
Global Tumor Marker Testing Market Research Report 2024
Global Minimally Invasive Tumor Treatment Technology Market Research Report 2024
Global Non invasive Tumor Detection Market Research Report 2024
Medical Imaging Technologies for Oncology Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions